Zobrazeno 201 - 210
of 158 513
pro vyhledávání: ''
Autor:
Li, Lilin, An, Jung Nam, Lee, Jeonghwan, Shin, Dong Jin, Zhu, Shi Mao, Kim, Jin Hyuk, Kim, Dong Ki, Ryu, Dong-Ryeol, Kim, Sejoong, Lee, Jung Pyo
Publikováno v:
Kidney Research and Clinical Practice
Background Hepatocyte growth factor (HGF)/cMet pathway is necessary for repair and regeneration following acute kidney injury (AKI). We evaluated the clinical potential of plasma HGF and soluble cMet as prognostic biomarkers for severe AKI requiring
Autor:
Ajin Cho, Ja-Ryong Koo, Juhee Kim, Jung-Woo Noh, Young-Ki Lee, Hayne Cho Park, Kyu Sang Yun, Jong-Woo Yoon, Do Hyoung Kim
Publikováno v:
Kidney Research and Clinical Practice
Introduction Despite of the routine use of erythropoietin in hemodialysis patients to correct anemia, its administration route's effects on hemoglobin variability and cardiovascular events remain elusive. Herein, we determined different erythropoieti
Autor:
Serap Sivri, Tevfik Karagöz, Kısmet Çıkı, Turgay Coşkun, Ali Dursun, Hayrettin Hakan Aykan, Ayşegül Tokatlı, Berrak Bilginer Gürbüz
Publikováno v:
Volume: 46, Issue: 4 1419-1425
Cukurova Medical Journal
Cukurova Medical Journal
Amaç: Bu çalışma, tip 1 tirozinemi hastalarında kardiyomiyopati sıklığını ve rutin olarak kullanılan nitisinon tedavisine yanıtını retrospektif olarak değerlendirmeyi amaçlamıştır.Gereç ve Yöntem: Tanımlayıcı ve kesitsel olan
Autor:
Giammarco Mocci, S. Rodinò, Nicola Della Valle, Camilla Graziosi, Tiziana Larussa, Irene Maria Bambina Bergna, Walter Elisei, Giovanni Maconi, Francesco Luzza, Giacomo Forti, Rodolfo Sacco, Roberto Faggiani, Roberto Lorenzetti, Leonardo Allegretta, Marcello Picchio, Giuseppe Pranzo, Antonio Penna, Antonio Ferronato, Raffaele Colucci, Ladislava Sebkova, Costantino Zampaletta, Antonio de Medici, Antonio Tursi
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 30:456-461
Background and Aims: Several studies have found Golimumab (GOL) effective and safe in the short-term treatment of ulcerative colitis (UC), but few long-term data are currently available from real world. Our aim was to assess the long-term real-life e
Publikováno v:
British Journal of Clinical Pharmacology. 88:2019-2034
Aim Anti-human epidermal growth factor receptor 2 (HER2) therapy is an effective treatment for HER2-positive gastric and breast malignancies. However, the efficacy of HER2-targeted therapy in non-small cell lung cancer (NSCLC) patients with HER2 alte
Autor:
Laura K. Whited, Jose Banchs, Richard E. Champlin, Uday R. Popat, Elizabeth J. Shpall, Gabriela Rondon, Rima M. Saliba, Jason Yeh
Publikováno v:
Blood Advances
Key Points The incidence of acute cardiac toxicity remains low and manageable after matched allo-HCT in the era of PTCy prophylaxis.Older age, hypertension, arrhythmia, diabetes, and cardiac comorbidities increase this risk of cardiac toxicity but PT
Autor:
Fasiha Kanwal, Jennifer R. Kramer, Jianliang Dai, Liang Li, Hashem B. El-Serag, Yamini Natarajan, Xian Yu
Publikováno v:
Hepatology. 75:1420-1428
BACKGROUND AND AIMS In patients with nonalcoholic fatty liver disease (NAFLD), those with type 2 diabetes (DM) have a high risk of progression to hepatocellular carcinoma (HCC). However, the determinants of HCC risk in these patients remain unclear.
Autor:
Ryuichiro Maekawa, Suketo So, Soichi Itaba, Hyonji Kim, Masahiro Yamasaki, Michihiko Shibata, Tatsuyuki Watanabe, Keiichiro Kume, Yasuhiro Takaki, Shinsuke Kumei, Noritaka Takatsu, Shigeo Nakamura, Ryosuke Sakemi, Masaru Harada, Hirotada Akiho, Toshihiro Sakurai, Ichiro Yoshikawa
Publikováno v:
Internal Medicine
Objective Real-world data of adalimumab (ADA) in the treatment of ulcerative colitis (UC) are scarce. We aimed to study the ADA response rates and predictors of response in UC treatment. Methods This observational, prospective and multi-center study
Autor:
Takashi Koyama, Yosuke Uenishi, Toshihide Yokoyama, Yoshihisa Tsuji, Masayuki Ueno, Motowo Mizuno, Etsuji Ishida
Publikováno v:
Internal Medicine
We herein report a case of fatal pancreatitis induced by an immune checkpoint inhibitor. A 62-year-old man with cancer of unknown primary was treated with pembrolizumab. After 12 cycles, immune-related pneumonitis developed and was treated with predn
Autor:
Umair Masood, Priya Grewal, Joseph A. Odin, Lindsey Channen, Jawad Ahmad, Nitzan C. Roth, Varun Kesar
Publikováno v:
Liver Transpl
Drug induced liver injury (DILI) due to medications and herbal and dietary supplements (HDS) is a major cause of acute liver injury leading to liver transplantation (LT). This study used United Network for Organ Sharing LT data to analyze severe HDS